Prepare for Your Consultation
We will need to gather as much information as possible about your medical history.
Before Your Visit
The first step is to read and complete the questionnaire that you can download here:
Feel free to contact us if anything needs clarification. If you have doubts or missing information, don't worry — we will review everything during your first consultation. Patient Form (PDF)
OnTimeDx® by TumoVance®
OnTimeDx® by TumoVance® is the latest Multi-Cancer Early Detection (MCED) solution — a simple blood test with no invasive procedure. It represents a revolution in early cancer screening. Advances in proteomics research over the last two years now make it possible to detect a tumor at its earliest stage — from 24 months before symptoms appear, and even up to 6 months before imaging can reveal it. At this stage, the cure is almost guaranteed*
Unlike ctDNA or methylation tests that require DNA release from the nucleus, tests targeting surface proteins offer higher sensitivity for small tumors because these markers are shed directly from the cell membrane, even at minimal tumor volumes.
*For these five cancers, the 5-year survival rates for proteomic-detected Stage I versus late-symptomatic diagnosis are: Breast: 99% (28%), Colon: 92% (14%), Prostate/OSCC: 90–95% (30–38%), Lung: 82–93% (7%), and Pancreas: >80% (3%).
What to Expect
Your journey to better cancer care
Complete Medical Review
We thoroughly review all your prior treatments, imaging studies, pathology reports, and molecular data to build a complete picture of your condition.
Treatment Plan
Treatment optimization, targeted therapy, or immunotherapy, we can refer you to world-class care abroad to our partners using thise medical technologies: NanoKnife (IRE) for inoperable tumors in the prostate, pancreas, or liver (destroys cancer while preserving vital nerves and vessels, when surgery is not possible), Blue Light TURBT for the bladder (detects hidden tumors for better resection and lower relapses), CyberKnife/Varian Edge stereotaxic radiotherapy for lung/brain (painless robotic), and Lutetium-177/Actinium-225 for metastatic prostate cancers (targeted molecular therapy).
Personnalized antitumor vaccine
We offer a fully personalized anti-tumor vaccine created from your own tumor sample. Using advanced NGS, we identify tumor-specific mutations and select neoantigens to design a therapy unique to you. When other treatments fail, this approach aims to train your immune system to recognize and fight the tumor. Full program available from $90,000. .